Godavari Drugs Current Share Price | Godavari Drugs Stock Screener
GODAVARI
Pharmaceuticals
Godavari Drugs Current Stock Price Today
Live Share Price BSE
₹112.25
▲
2.30 (2.09%)
As of September 18, 2026, the live Godavari Drugs share price (BSE: GODAVARI) is ₹112.25, up 2.09% from the previous close, with shares trading between ₹108.43 and ₹113.83 in today's trading session, and a 52-week range of ₹70.24–₹130.15.
Browse GODAVARI complete financial statements to support your investment research.
Use the Godavari Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Godavari Drugs Market Cap
₹129.84 Cr.
GODAVARI P/E Ratio (TTM)
31.66
Godavari Drugs P/B Ratio
1.70
EPS (TTM)
₹5.43
Dividend Yield
-
Debt to Equity
1.23
GODAVARI 52 Week High
₹130.15
Godavari Drugs 52 Week Low
₹70.24
Operating Margin
9.00%
Profit Margin
3.60%
GODAVARI Revenue (TTM)
₹111.00
EBITDA
₹11.00
Net Income
₹4.00
Total Assets
₹200.00
Total Equity
₹76.00
Godavari Drugs Current Share Price Chart
Track the current Godavari Drugs share price and stock price with an interactive chart. Analyse GODAVARI price trends, trading volume, historical performance, and volatility across different timeframes — the complete Godavari Drugs stock quote in one place.
Godavari Drugs Company Profile - Fundamental Screener
Screen Godavari Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GODAVARI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE362C01012
Godavari Drugs Balance Sheet Screener
Screen GODAVARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 200 | 143 | 135 | 121 | 101 | 91 | 84 | 74 | 63 | 56 |
| Current Assets | 112 | 79 | 89 | 87 | 74 | 68 | 61 | 57 | 47 | 43 |
| Fixed Assets | 30 | 33 | 27 | 25 | 26 | 22 | 14 | 15 | 15 | 13 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 40 | 27 | 14 | 14 | 14 | 16 | 12 | 9 | 9 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 76 | 43 | 39 | 33 | 30 | 24 | 20 | 18 | 17 | 16 |
| Share Capital | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 60 | 36 | 31 | 26 | 22 | 17 | 13 | 11 | 10 | 9 |
Godavari Drugs Income Statement Screener - Profit & Revenue Analysis
Screen Godavari Drugs income statement and profit fundamentals.
Analyze GODAVARI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Godavari Drugs share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111 | 107 | 114 | 157 | 160 | 161 | 123 | 96 | 84 | 65 | 76 | 71 | 55 |
| Expenses | 100 | 96 | 102 | 143 | 150 | 150 | 113 | 90 | 78 | 60 | 70 | 67 | 49 |
| EBITDA | 11 | 11 | 13 | 14 | 11 | 12 | 10 | 6 | 6 | 5 | 6 | 5 | 6 |
| Operating Profit % | 9.00% | 10.00% | 10.00% | 8.00% | 6.00% | 7.00% | 8.00% | 6.00% | 7.00% | 6.00% | 7.00% | 6.00% | 11.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 4 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 1 |
| Profit Before Tax | 5 | 5 | 6 | 7 | 5 | 7 | 6 | 2 | 2 | 1 | 3 | 2 | 5 |
| Tax | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 4 | 4 | 4 | 6 | 4 | 5 | 4 | 2 | 1 | 1 | 2 | 1 | 4 |
| EPS | 5.20 | 5.43 | 5.82 | 7.37 | 5.03 | 6.97 | 5.48 | 2.66 | 1.60 | 1.10 | 2.40 | 1.79 | 4.84 |
Godavari Drugs Cash Flow Screener - Liquidity Fundamentals
Screen GODAVARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 11 | 18 | 13 | 11 | 1 | 6 | 4 | 4 | 5 |
| Investing Activities | -26 | -20 | -13 | -9 | -5 | -1 | -7 | -2 | -3 | -3 |
| Financing Activities | 37 | 8 | -6 | -4 | -6 | 0 | 0 | -2 | 0 | -2 |
| Net Cash Flow | 12 | 0 | -1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Godavari Drugs Shareholding Pattern Screener
See Godavari Drugs shareholding pattern with promoter, FII, and DII holdings.
Check Godavari Drugs promoter holding and ownership changes for GODAVARI on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 40.23% | 40.23% | 52.63% | 52.63% | 52.61% | 52.61% | 53.16% | 53.16% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.47% | 2.74% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 40.90% | 42.76% | 39.93% | 37.09% | 37.05% | 36.88% | 39.10% | 38.96% |
| Other Holding | 16.40% | 14.28% | 6.95% | 9.78% | 9.84% | 10.01% | 7.24% | 7.38% |
| Shareholder Count | 7,323 | 6,722 | 7,881 | 7,828 | 7,720 | 7,483 | 7,005 | 7,044 |
Godavari Drugs Share Dividend Screener - Share Yield Analysis
Check Godavari Drugs dividend history with payout and yield data.
View Godavari Drugs dividend details including ex-dates and amounts for GODAVARI stock.
Godavari Drugs Stock Index Membership
See which indices include Godavari Drugs stock.
Check GODAVARI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Godavari Drugs Market Events Screener - Corporate Actions
Get Godavari Drugs corporate actions including splits, bonuses, and buybacks.
Check Godavari Drugs stock events that may affect GODAVARI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | -7.65% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | -6.54% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 3.74% |
| 2026-02-12 | 2026-02-12 | Extraordinary General Meeting | NA | 4.51% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | -4.07% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.47% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | 4.77% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 4.42% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.50% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -1.51% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.33% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | 52.12% |
Godavari Drugs Competitors Screener - Peer Comparison
Screen GODAVARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Godavari Drugs Company Announcements - News Screener
Screen GODAVARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-09 | Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) Regulations | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | 39Th AGM To Be Held On 25Th Sep 2026 At 11.00 A.M. Through Video Conferencing | - |
| 2026-09-01 | 38Th AGM To Be Held On 25.09.2026 - Book Closure - 19.09.2026 - 25.09.2026 (Both Days) And Evoting Cutoff Date. | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-08-31 | Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Clause III(A) Of The Memorandum Of Association And Approval Of Revised Notice Of The 38Th Annual General Meeting | - |
| 2026-08-17 | Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026 | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-14 | Submission Of Un-Audited Standalone Financial Results For The Quarter Ended As On June 30 2026 | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026 | - |
| 2026-08-11 | Update on board meeting | - |
| 2026-08-10 | Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-07-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-23 | Closure of Trading Window | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended March 31 2026 | - |
| 2026-05-27 | Financial Results For Period Ended 31St March2026 | - |
| 2026-05-27 | Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May2026 | - |